Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07434518
Eligibility Criteria:
Inclusion Criteria:
* Histologically or cytologically confirmed extensive-stage small cell lung cancer;
* Age ≥ 18 years;
* The investigator determines that the patient is eligible for or is already receiving adebrelimab treatment.
Exclusion Criteria:
* Patients concurrently receiving other immune-modulating drugs or therapies;
* Patients currently participating in other interventional studies;
* Patients with concurrent other malignancies;
* Patients with missing key study-related data.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT07434518
Study Brief:
Protocol Section:
NCT07434518